BioCentury
ARTICLE | Company News

Deltanoid, Pfizer deal

January 20, 2003 8:00 AM UTC

Deltanoid granted PFE an option to acquire development and marketing rights to its 2MD, an analog of vitamin D, to treat osteoporosis. PFE also would receive rights to certain other Deltanoid vitamin...